Publicacións en colaboración con investigadores/as de University of the Witwatersrand (66)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Blood Composite Scores in Patients with Systemic Lupus Erythematosus

    Biomedicines, Vol. 11, Núm. 10

  3. Challenges in the diagnosis of polymyalgia rheumatica and related giant cell arteritis

    Expert Review of Clinical Immunology, Vol. 19, Núm. 5, pp. 517-526

  4. Circulating interleukin-6 and cardiovascular disease risk in patients with rheumatoid arthritis with low disease activity due to active therapy

    Clinical and experimental rheumatology, Vol. 41, Núm. 7, pp. 1537-1543

  5. Disease Activity Is More Associated with IL-1 Than with IL-6 in Patients with Rheumatoid Arthritis

    Life, Vol. 13, Núm. 1

  6. Endothelin-1 as a Biomarker of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Associated with Autoimmune Diseases

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  7. Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus

    Frontiers in Immunology, Vol. 14

  8. Genomic investigations of unexplained acute hepatitis in children

    Nature, Vol. 617, Núm. 7961, pp. 564-573

  9. Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data

    The Lancet Infectious Diseases, Vol. 23, Núm. 7, pp. 856-866

  10. Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus

    Antioxidants, Vol. 12, Núm. 8

  11. Relationship of Fibroblast Growth Factor 23 Serum Levels with Disease Characteristics in Systemic Lupus Erythematosus Patients

    Biomolecules, Vol. 13, Núm. 8

  12. Serum Levels of Lipoprotein Lipase Are Increased in Patients with Inflammatory Bowel Disease

    International journal of molecular sciences, Vol. 24, Núm. 6

  13. Serum Levels of Transforming Growth Factor Beta 1 in Systemic Lupus Erythematosus Patients

    Biomolecules, Vol. 13, Núm. 1

  14. Transforming growth factor beta 1 is associated with subclinical carotid atherosclerosis in patients with systemic lupus erythematosus

    Arthritis Research and Therapy, Vol. 25, Núm. 1